637 related articles for article (PubMed ID: 1660811)
1. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
[TBL] [Abstract][Full Text] [Related]
3. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
[TBL] [Abstract][Full Text] [Related]
4. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
5. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line.
Sijts AJ; De Bruijn ML; Nieland JD; Kast WM; Melief CJ
Eur J Immunol; 1992 Jun; 22(6):1639-42. PubMed ID: 1601045
[TBL] [Abstract][Full Text] [Related]
7. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
Majlessi L; Bordenave G
Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
[TBL] [Abstract][Full Text] [Related]
8. Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein.
Schoel B; Zügel U; Ruppert T; Kaufmann SH
Eur J Immunol; 1994 Dec; 24(12):3161-9. PubMed ID: 7805744
[TBL] [Abstract][Full Text] [Related]
9. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
[TBL] [Abstract][Full Text] [Related]
10. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
12. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
Rock KL; Fleischacker C; Gamble S
J Immunol; 1993 Feb; 150(4):1244-52. PubMed ID: 8381832
[TBL] [Abstract][Full Text] [Related]
13. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
14. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
15. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis.
Christinck ER; Luscher MA; Barber BH; Williams DB
Nature; 1991 Jul; 352(6330):67-70. PubMed ID: 2062379
[TBL] [Abstract][Full Text] [Related]
16. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
Franksson L; Petersson M; Kiessling R; Kärre K
Eur J Immunol; 1993 Oct; 23(10):2606-13. PubMed ID: 8405061
[TBL] [Abstract][Full Text] [Related]
17. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
Anjuère F; Horvath C; Cerottini JC; Luescher IF
Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
[TBL] [Abstract][Full Text] [Related]
18. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
19. Lessons from T cell responses to virus induced tumours for cancer eradication in general.
Melief CJ; Kast WM
Cancer Surv; 1992; 13():81-99. PubMed ID: 1423326
[TBL] [Abstract][Full Text] [Related]
20. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]